GO:0008195 phosphatidate phosphatase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008195 phosphatidate phosphatase activity catalyzes the dephosphorylation of phosphatidic acid to diacylglycerol, a critical step in lipid metabolism.
• The reaction is conserved from yeast to humans and is essential for membrane phospholipid synthesis and lipid homeostasis.
• Key enzymes include yeast Pah1 and mammalian lipins (LPIN1, LPIN2, LPIN3), which are regulated by phosphorylation and cellular cues [1, 5, 8].
• Phosphatidate phosphatase activity is induced during lipogenesis in oleaginous yeast and is tightly regulated by inositol and protein kinases [2, 6, 8].
• Dysregulation of phosphatidate phosphatase is linked to metabolic diseases, cancer, and lipodystrophies [1, 4].
• Studying this activity requires assays, genetic models, and CRISPR-based editing to dissect its roles in health and disease [3, 7].
Description
Phosphatidate phosphatase activity (GO:0008195) is a fundamental enzymatic function that removes a phosphate group from phosphatidic acid (PA) to produce diacylglycerol (DAG) and inorganic phosphate. This reaction sits at a branch point in lipid metabolism, directing intermediates toward the synthesis of membrane phospholipids, triacylglycerols, and signaling lipids. Because DAG and PA serve as both structural components and signaling molecules, the enzyme that catalyzes this step exerts profound control over cellular lipid homeostasis. In eukaryotic cells, phosphatidate phosphatase activity is carried out by evolutionarily conserved enzymes, including yeast Pah1 and mammalian lipins, which are subject to multiple layers of regulation [5, 8]. The importance of this activity extends beyond basic lipid biochemistry; it influences membrane biogenesis, energy storage, and cell signaling, making it a subject of intense research interest [1, 4]. Understanding phosphatidate phosphatase activity is therefore essential for researchers studying metabolic disorders, cancer, and cellular stress responses [1, 3].
phosphatidate phosphatase activity At A Glance
| GO ID | GO:0008195 |
|---|---|
| GO term | phosphatidate phosphatase activity |
| Ontology | molecular_function |
| Synonym | phosphatidic acid phosphatase activity; phosphatidate phosphohydrolase activity; 3-sn-phosphatidate phosphohydrolase activity |
| Major function | Catalyzes the dephosphorylation of phosphatidic acid to diacylglycerol and phosphate |
| Reaction | 1,2-diacylglycerol 3-phosphate + H2O = 1,2-diacyl-sn-glycerol + phosphate |
| Cofactors | Requires Mg2+ or Mn2+ for activity (as reported for yeast Pah1 and mammalian lipins) |
| Localization | Membrane-associated, primarily at the endoplasmic reticulum and nuclear envelope |
What Is GO:0008195?
Phosphatidate phosphatase activity is defined as the catalysis of the reaction: a 1,2-diacylglycerol 3-phosphate (phosphatidic acid) plus water yields a 1,2-diacyl-sn-glycerol (diacylglycerol) plus phosphate. This hydrolase activity specifically targets the phosphate ester bond of phosphatidic acid, releasing inorganic phosphate and generating diacylglycerol. The reaction is reversible in principle but physiologically favors dephosphorylation, and it is a key step in the Kennedy pathway for glycerolipid synthesis.
Why Is phosphatidate phosphatase activity Important in Cell Biology?
Phosphatidate phosphatase activity is a central node in lipid metabolism, controlling the balance between phosphatidic acid and diacylglycerol, two lipids with distinct signaling and biosynthetic roles. By converting PA to DAG, it supplies substrate for the synthesis of phosphatidylcholine, phosphatidylethanolamine, and triacylglycerols, thereby influencing membrane composition and energy storage. In addition, the activity is regulated by mechanical cues, hormones, and nutrients, linking it to systemic metabolic control [1, 8]. Dysregulation of this activity has been implicated in obesity, insulin resistance, cancer, and rare genetic disorders, underscoring its biomedical relevance [1, 4].
• Controls the balance between phosphatidic acid and diacylglycerol, affecting membrane phospholipid synthesis.
• Regulates triacylglycerol synthesis and lipid droplet formation in lipogenic tissues.
• Modulates cell signaling through PA and DAG second messengers.
• Is induced during lipogenesis in oleaginous yeast, with implications for biofuel production.
• Is regulated by inositol in Saccharomyces cerevisiae, linking lipid synthesis to nutrient availability.
• Phosphorylation by Hsl1 inhibits Pah1 activity, providing a mechanism for cell cycle control of lipid synthesis.
• Mutations in lipin genes cause lipodystrophy and myopathy in humans.
• Altered phosphatidate phosphatase activity is observed in cancer cells and may support tumor growth.
• Serves as a target for understanding membrane remodeling during stress responses.
• Provides a model for studying enzyme regulation by phosphorylation and membrane association.
Molecular Mechanism of phosphatidate phosphatase activity
Substrate recognition and binding
In simple terms: The enzyme grabs phosphatidic acid and positions it for chemical attack.
Phosphatidate phosphatase enzymes recognize phosphatidic acid (PA) as their primary substrate through a conserved catalytic core that includes a haloacid dehalogenase (HAD)-like domain. The enzyme binds the PA molecule at the membrane interface, where the substrate is embedded in the lipid bilayer. Structural studies of yeast Pah1 reveal that a conserved DxDxT motif coordinates a metal ion (Mg2+ or Mn2+) that activates a water molecule for nucleophilic attack on the phosphate group [5, 7]. The catalytic core also contains residues that stabilize the transition state and facilitate product release.
Catalytic mechanism and metal dependence
In simple terms: A metal ion helps water break the phosphate bond, releasing diacylglycerol and phosphate.
The catalytic mechanism of phosphatidate phosphatase involves a two-step process: first, the metal ion coordinates the phosphate oxygen, increasing its electrophilicity; second, an activated water molecule attacks the phosphorus, leading to cleavage of the phosphate ester bond and formation of diacylglycerol and inorganic phosphate [3, 5]. Mutagenesis studies of yeast Pah1 have identified critical active-site residues, including aspartates and a threonine, that are essential for catalysis. The reaction is dependent on divalent cations, with Mg2+ being preferred in most assays.
Regulation by phosphorylation
In simple terms: Adding phosphate groups to the enzyme can turn its activity off or on.
Phosphatidate phosphatase activity is tightly regulated by reversible phosphorylation. In Saccharomyces cerevisiae, the protein kinase Hsl1 phosphorylates Pah1 at specific serine residues, inhibiting its phosphatidate phosphatase activity and thereby reducing lipid synthesis. This phosphorylation-dependent inhibition links lipid metabolism to cell cycle progression and nutrient signaling. Conversely, dephosphorylation by phosphatases such as Nem1-Spo7 activates Pah1, allowing it to associate with membranes and catalyze the reaction. In mammalian cells, lipin-1 activity is regulated by mechanical cues through a mechanism involving SREBP and the extracellular matrix.
Membrane association and localization
In simple terms: The enzyme must attach to membranes to find its substrate.
Phosphatidate phosphatase enzymes are peripheral membrane proteins that require specific targeting to the endoplasmic reticulum (ER) and nuclear envelope for activity. In yeast, Pah1 is recruited to the nuclear/ER membrane by the Nem1-Spo7 phosphatase complex, which dephosphorylates Pah1 and promotes its membrane binding. The catalytic core of Pah1 contains a conserved amphipathic helix that facilitates membrane interaction. Mutations that disrupt membrane association abolish phosphatidate phosphatase activity and lead to defects in lipid homeostasis.
Role in phospholipid synthesis
In simple terms: The product DAG is used to build major membrane lipids.
The diacylglycerol produced by phosphatidate phosphatase is a key intermediate in the synthesis of phosphatidylcholine and phosphatidylethanolamine via the Kennedy pathway. In yeast, phosphatidate phosphatase activity regulates the expression of phosphatidylserine synthase, thereby coordinating phospholipid synthesis with the availability of DAG. This regulatory feedback ensures that membrane lipid composition is maintained within physiological limits. Disruption of this coordination leads to abnormal membrane proliferation and lipid droplet accumulation.
Key Genes Involved in GO:0008195 phosphatidate phosphatase activity
The following genes and proteins are central to phosphatidate phosphatase activity across model organisms and humans.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PAH1 (yeast) | Encodes the primary phosphatidate phosphatase in Saccharomyces cerevisiae | Model for studying enzyme regulation and membrane association [5, 7] |
| LPIN1 (human) | Encodes lipin-1, a phosphatidate phosphatase in mammals | Linked to lipodystrophy, myopathy, and metabolic disorders |
| LPIN2 (human) | Encodes lipin-2, involved in lipid metabolism | Mutations cause Majeed syndrome |
| LPIN3 (human) | Encodes lipin-3, a less characterized lipin | Potential role in intestinal lipid absorption |
| NEM1 (yeast) | Phosphatase that dephosphorylates Pah1 to activate it | Regulates Pah1 membrane recruitment |
| SPO7 (yeast) | Regulatory subunit of Nem1 phosphatase complex | Required for Pah1 activation |
| HSL1 (yeast) | Protein kinase that phosphorylates and inhibits Pah1 | Links cell cycle to lipid synthesis |
| SREBP (human) | Transcription factor regulating lipin-1 expression | Mediates mechanical cue regulation of lipid metabolism |
| DGK (human) | Diacylglycerol kinase, reverses reaction by converting DAG to PA | Opposing enzyme in the PA/DAG cycle |
| CDS (yeast) | CDP-diacylglycerol synthase, uses PA for phospholipid synthesis | Competes with Pah1 for PA |
| PSS (yeast) | Phosphatidylserine synthase, regulated by phosphatidate phosphatase | Links Pah1 to phospholipid synthesis |
| PAP (mammalian) | Phosphatidate phosphatase enzymes in mammals | Include lipins and other isoforms |
| Lipin-1 (mouse) | Mouse ortholog of LPIN1 | Knockout models show lipodystrophy and neuropathy |
| Pah1 (yeast) | Phosphatidate phosphatase, regulated by phosphorylation | Key model for structure-function studies |
| HAD domain | Catalytic domain in phosphatidate phosphatases | Target for mutagenesis to dissect mechanism |
| Mg2+ | Divalent cation cofactor | Required for catalytic activity in vitro |
How Is phosphatidate phosphatase activity Regulated?
Phosphatidate phosphatase activity is regulated at multiple levels. In yeast, the Nem1-Spo7 phosphatase complex dephosphorylates Pah1, promoting its membrane association and activation. Conversely, the Hsl1 kinase phosphorylates Pah1, inhibiting its activity and reducing lipid synthesis. Inositol availability also regulates phosphatidate phosphatase activity in Saccharomyces cerevisiae, linking lipid synthesis to nutrient status. In mammalian cells, mechanical cues from the extracellular matrix regulate lipin-1 activity through SREBP-dependent pathways. These regulatory mechanisms ensure that phosphatidate phosphatase activity is tuned to cellular demands for membrane lipids and energy storage.
phosphatidate phosphatase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LPIN1 | Lipodystrophy, myopathy, rhabdomyolysis | Knockout mouse, patient-derived iPSCs |
| LPIN2 | Majeed syndrome (autoinflammatory) | Point-mutation knock-in in cell lines |
| LPIN3 | Metabolic syndrome, intestinal lipid absorption | Overexpression and knockout in Caco-2 cells |
| PAH1 (yeast) | Lipid homeostasis defects | Yeast deletion mutants and point mutations |
| SREBP | Cancer, metabolic reprogramming | CRISPR knockout in cancer cell lines |
Lipin-1 and metabolic disorders
Mutations in LPIN1 cause recurrent acute myoglobinuria in children, a condition characterized by muscle breakdown and rhabdomyolysis. Lipin-1 deficiency in mice leads to lipodystrophy, insulin resistance, and peripheral neuropathy, highlighting its role in adipose tissue development and systemic metabolism. These findings establish phosphatidate phosphatase activity as a critical determinant of metabolic health.
Phosphatidate phosphatase in cancer
Altered phosphatidate phosphatase activity has been observed in cancer cells, where it may support increased membrane synthesis and proliferation. The mechanical properties of the tumor microenvironment can regulate lipin-1 and SREBP, linking lipid metabolism to cancer progression. Targeting phosphatidate phosphatase activity is therefore being explored as a potential therapeutic strategy in oncology.
Infectious and inflammatory diseases
In Saccharomyces cerevisiae, phosphatidate phosphatase activity is regulated by inositol, which affects membrane phospholipid synthesis. While yeast is not a pathogen, these studies provide a model for understanding how lipid metabolism responds to environmental signals, with implications for fungal infections and inflammatory conditions.
From phosphatidate phosphatase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of phosphatidate phosphatase activity affect lipid droplet formation? | PAH1 knockout yeast or LPIN1 knockout mammalian cells |
| How does phosphorylation regulate enzyme activity? | Point mutations at phosphorylation sites (e.g., Pah1 S110A) |
| What is the effect of a disease-associated mutation on enzyme function? | Knock-in of LPIN1 mutations in HEK293 or patient iPSCs |
| Where is the enzyme localized in live cells? | Tagged knock-in of PAH1 or LPIN1 with GFP |
| Can overexpression rescue lipid synthesis defects? | Overexpression of wild-type or mutant LPIN1 in knockout cells |
| What genes interact with phosphatidate phosphatase? | CRISPR library screening in yeast or mammalian cells |
How to Study the phosphatidate phosphatase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled PA assay | Enzymatic release of phosphate from PA | Quantifying phosphatidate phosphatase activity in cell lysates |
| Thin-layer chromatography | Separation of lipids (PA, DAG) | Analyzing reaction products |
| Western blot | Protein expression and phosphorylation status | Assessing Pah1 or lipin levels |
| Fluorescence microscopy | Subcellular localization of tagged enzymes | Visualizing membrane association |
| CRISPR knockout | Loss of gene function | Studying LPIN1/PAH1 roles in lipid metabolism |
| Site-directed mutagenesis | Specific amino acid changes | Mapping catalytic and regulatory residues |
| Lipidomics | Global lipid composition | Quantifying PA and DAG levels |
| Co-immunoprecipitation | Protein-protein interactions | Identifying regulators like Nem1-Spo7 |
Enzymatic assays for phosphatidate phosphatase activity
Direct measurement of phosphatidate phosphatase activity is typically performed using radiolabeled or fluorescent phosphatidic acid substrates, followed by separation of products by thin-layer chromatography or high-performance liquid chromatography. These assays require optimal pH, metal ion cofactors, and membrane-mimicking conditions to reflect physiological activity. Recent reviews provide detailed protocols for both yeast and mammalian systems.
Genetic and biochemical approaches in yeast
Saccharomyces cerevisiae is a powerful model for studying phosphatidate phosphatase because of its tractable genetics and conserved lipid metabolism [5, 7]. Deletion of PAH1 results in reduced phosphatidate phosphatase activity and abnormal lipid composition, which can be rescued by plasmid-borne wild-type or mutant alleles. Phosphorylation site mutants and tagged versions of Pah1 allow researchers to dissect regulation and localization.
Mammalian cell models and CRISPR editing
In mammalian cells, CRISPR-Cas9 knockout of LPIN1, LPIN2, or LPIN3 enables loss-of-function studies to assess their roles in lipid metabolism and signaling. Point mutations can be introduced to mimic disease-associated variants or to abrogate catalytic activity. Overexpression of wild-type or mutant lipins is used to test gain-of-function effects on lipid droplet formation and membrane composition.
Omics and imaging approaches
Transcriptomics and proteomics can reveal global changes in lipid-related gene expression upon modulation of phosphatidate phosphatase activity. Fluorescence microscopy of tagged enzymes allows visualization of their subcellular localization and dynamics. Lipidomics by mass spectrometry quantifies changes in phosphatidic acid, diacylglycerol, and other lipid species.
How CRISPR Can Be Used to Study GO:0008195 phosphatidate phosphatase activity
Knockout
CRISPR-Cas9 knockout of LPIN1, LPIN2, or LPIN3 in mammalian cells abolishes phosphatidate phosphatase activity, leading to accumulation of phosphatidic acid and reduced diacylglycerol. These models are used to study the consequences for lipid droplet formation, membrane phospholipid composition, and cell signaling. In yeast, PAH1 knockout is a standard tool for dissecting the enzyme's role in lipid homeostasis.
Point Mutation
Point mutations can be introduced into the catalytic core of phosphatidate phosphatase genes to abrogate enzymatic activity without affecting protein stability. For example, mutation of the conserved aspartate in the DxDxT motif of yeast Pah1 eliminates activity, providing a clean loss-of-function model. Disease-associated mutations in LPIN1 can also be knocked in to study their effects on enzyme function and cellular lipid metabolism.
Knock-in
Knock-in of tagged versions of phosphatidate phosphatase genes (e.g., GFP or FLAG) allows real-time visualization and biochemical purification of the enzyme. This approach is valuable for studying membrane association dynamics and post-translational modifications. Knock-in of patient-specific mutations into the endogenous locus provides a physiologically relevant model for disease research.
Overexpression
Overexpression of wild-type or mutant phosphatidate phosphatase genes can rescue loss-of-function phenotypes or induce gain-of-function effects. In yeast, overexpression of Pah1 leads to increased diacylglycerol and triacylglycerol synthesis, while overexpression of catalytically dead mutants serves as a control. In mammalian cells, overexpression of lipin-1 isoforms is used to study their differential roles in lipid metabolism.
How EDITGENE Supports phosphatidate phosphatase activity Research
Researchers studying phosphatidate phosphatase activity-related genes often need to determine whether a candidate gene is causally involved in lipid metabolism, disease, or cellular stress responses. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for phosphatidate phosphatase activity research.
Frequently Asked Questions About phosphatidate phosphatase activity
What is phosphatidate phosphatase activity?
Phosphatidate phosphatase activity (GO:0008195) is the enzymatic removal of a phosphate group from phosphatidic acid to produce diacylglycerol and inorganic phosphate.
What genes are involved in phosphatidate phosphatase activity?
Key genes include PAH1 in yeast and LPIN1, LPIN2, and LPIN3 in humans, which encode the enzymes that carry out this activity [1, 5].
How is phosphatidate phosphatase activity regulated?
It is regulated by phosphorylation (e.g., by Hsl1 kinase), dephosphorylation (by Nem1-Spo7), and nutrient signals such as inositol [6, 8].
What diseases are associated with phosphatidate phosphatase activity?
Mutations in LPIN1 cause lipodystrophy and myopathy, and altered activity is linked to cancer and metabolic disorders.
What is the reaction catalyzed by phosphatidate phosphatase?
The reaction is: a 1,2-diacylglycerol 3-phosphate + H2O = a 1,2-diacyl-sn-glycerol + phosphate.
How can I measure phosphatidate phosphatase activity?
Enzymatic assays using radiolabeled or fluorescent phosphatidic acid, followed by product separation, are commonly used.
What model organisms are used to study phosphatidate phosphatase activity?
Saccharomyces cerevisiae (yeast) is a primary model, along with mammalian cell lines and mouse models [5, 7].
What are the synonyms for phosphatidate phosphatase activity?
Synonyms include phosphatidic acid phosphatase activity, phosphatidate phosphohydrolase activity, and 3-sn-phosphatidate phosphohydrolase activity.
How does phosphatidate phosphatase affect lipid metabolism?
It controls the balance between phosphatidic acid and diacylglycerol, influencing phospholipid and triacylglycerol synthesis.
Can CRISPR be used to study phosphatidate phosphatase activity?
Yes, CRISPR knockout, point mutation, and knock-in models are powerful tools to dissect the function of genes like LPIN1 and PAH1 [1, 7].
Conclusion
Phosphatidate phosphatase activity (GO:0008195) is a cornerstone of lipid metabolism, bridging phosphatidic acid and diacylglycerol to control membrane synthesis, energy storage, and signaling. Its evolutionary conservation and regulation by phosphorylation and nutrients make it a compelling subject for basic and translational research [5, 8]. Dysregulation of this activity contributes to metabolic diseases and cancer, highlighting its potential as a therapeutic target. Continued research using CRISPR models and advanced assays will further illuminate its roles in health and disease [3, 7].
References
- 1. Romani P et al.. 2019. Extracellular matrix mechanical cues regulate lipid metabolism through Lipin-1 and SREBP.. Nat Cell Biol 21(3):338-347 PMID: 30718857
- 2. Hardman D et al.. 2018. Phosphatidate phosphatase activity is induced during lipogenesis in the oleaginous yeast Yarrowia lipolytica.. Yeast 35(11):619-625 PMID: 30175530
- 3. Dey P et al.. 2020. A review of phosphatidate phosphatase assays.. J Lipid Res 61(12):1556-1564 PMID: 32963036
- 4. Carman GM et al.. 2018. Phosphatidate phosphatase regulates membrane phospholipid synthesis via phosphatidylserine synthase.. Adv Biol Regul 67:49-58 PMID: 28827025
- 5. Han GS et al.. 2024. Catalytic core function of yeast Pah1 phosphatidate phosphatase reveals structural insight into its membrane localization and activity control.. J Biol Chem 300(1):105560 PMID: 38097185
- 6. Morlock KR et al.. 1988. Regulation of phosphatidate phosphatase activity by inositol in Saccharomyces cerevisiae.. J Bacteriol 170(8):3561-6 PMID: 2841291
- 7. Stukey GJ et al.. 2025. Active site determinants of yeast Pah1 phosphatidate phosphatase activity and cellular functions.. J Biol Chem 301(8):110492 PMID: 40680843
- 8. Khondker S et al.. 2024. Protein kinase Hsl1 phosphorylates Pah1 to inhibit phosphatidate phosphatase activity and regulate lipid synthesis in Saccharomyces cerevisiae.. J Biol Chem 300(8):107572 PMID: 39009344
